Combined neutrophil-platelet score and hemoglobin level predict survival in esophageal squamous cell carcinoma patients treated with chemoradiotherapy.

Miao, Chuanwang; Zhu, Shan; Pan, Hong; Cao, Xiaolan; Yuan, Shuanghu; Hu, Xudong

Miao, Chuanwang; Zhu, Shan; Pan, Hong; Cao, Xiaolan; Yuan, Shuanghu; Hu, Xudong.

Afiliación

Miao C; School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, Jinan, Shandong Province, P.R. China.
Zhu S; Department of Radiotherapy, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong Province, P.R. China.
Pan H; Department of Head and Neck Radiotherapy, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong Province, P.R. China.
Cao X; Department of Head and Neck Radiotherapy, Shandong Provincial Western Hospital, Jinan, Shandong Province, P.R. China.
Yuan S; Central Sterile Supply Department, Shandong Cancer Hospital Affiliated to Shandong University, Jinan, Shandong Province, P.R. China.
Hu X; School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, Jinan, Shandong Province, P.R. China.

Oncotarget ; 8(50): 87971-87979, 2017 Oct 20.

Article en En | MEDLINE | ID: mdl-29152134

Palabras clave

chemoradiotherapy (CRT); esophageal squamous cell carcinoma (ESCC); hemoglobin (Hb); neutrophil-to-lymphocyte ratio (NLR); platelet-to-lymphocyte ratio (PLR)

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncotarget Año: 2017 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google